Navigation Links
OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing
Date:8/21/2014

NEW YORK, Aug. 21, 2014 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM) congratulates Immune Pharmaceuticals Inc., a biotechnology company, on its approval to list on The NASDAQ Capital Market.  Immune previously traded on OTCQX®, the best marketplace for established U.S. and global companies operated by OTC Markets Group.

Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO

"We congratulate Immune Pharmaceuticals on the successful execution of its growth strategy and achievement of this important milestone," said R. Cromwell Coulson, President and CEO of OTC Markets Group.  "OTCQX has provided its investors with an efficient, transparent and information-rich trading market so they can easily analyze, value and trade its securities.  We are proud to have helped contribute to Immune's success as a public company as it takes this next step."     

"Immune Pharma went public one year ago and started trading on OTCQX.  Over the past six months, we have significantly increased our daily trading volume and raised capital to prepare for execution on our clinical milestones and for up-listing.  On Thursday, August 21, 2014, we will begin trading on The Nasdaq Capital Market, enabling additional investors to participate in our story," said Dr. Daniel Teper, CEO of Immune.

OTCQX is the marketplace of choice for U.S. and global companies that are looking to execute their business plans and graduate to a U.S. stock exchange listing.  Immune is the sixth OTCQX company to graduate to the NYSE MKT or NASDAQ markets this year.  Others include: BioPath Holdings Inc., Cellectar Biosciences Inc., Gulf Coast Ultra Deep Loyalty Trust, RXI Pharmaceuticals Corp. and Sphere 3D Corp.

About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial marketplaces for 10,000 U.S. and global securities.  Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities.  We organize these securities into marketplaces to better inform investors of opportunities and risks – OTCQX®, The Best Marketplace; OTCQB®, The Venture Marketplace; and OTC Pink®, The Open Marketplace.  Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors.  To learn more about how we create better informed and more efficient financial marketplaces, visit www.otcmarkets.com.

OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.

Subscribe to the OTC Markets RSS Feed


'/>"/>
SOURCE OTC Markets Group Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Molecular Diagnostics Markets
2. Microarray Markets - 2013 Report Examines Companies that are Actively Developing and Marketing Microarray Instrumentation or Microarray Biochips
3. Stem Cell Markets - 2013 Report Examines the Use of Stem Cells in Developing New Therapies for Disease
4. BCC Research Publishes a New Report On Global Markets for Flow Cytometry
5. Globalizing Clinical Trials to Include Emerging Markets, New Life Science Webinar Hosted by Xtalks
6. BCC Research Publishes a New Report on Global Markets for Biochips
7. BCC Research Publishes a New Report On Global Markets for Rnai Technologies
8. Interventional Cardiology Devices - Emerging Markets 2009-2015
9. IDC MarketScape annovera la soluzione cloud-based di Veeva tra le principali soluzioni CRM dedicate alle scienze della vita
10. IDC MarketScape Named Cloud-based Veeva a Leader in Life Sciences CRM
11. Point of Care Diagnostic Testing: World Markets Report 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Report" report to their offering. ... This report analyzes the Global market for ... and forecasts are provided for the period 2014 through 2022. Market ... The report profiles 25 companies including many key and ...
(Date:3/24/2017)... 24, 2017 Agenus Inc. (NASDAQ: AGEN), an ... and cancer vaccines, today announced participation at the following ... William Blair and Maidstone Life Sciences conference "Cancer Immunotherapy ... New York, NY . Agenus will ... at 9:40 am: Robert B. Stein , M.D., ...
(Date:3/23/2017)... , March 23, 2017  Northwest Biotherapeutics ... DCVax® personalized immune therapies for solid tumor cancers, ... $7.5 million financing it announced last Friday, March ... to several institutional investors securities totaling 28,843,692 shares, ... share, and 10,000,000 shares of Class C Warrants ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... was recently selected by the Connecticut Technology Council (CTC) as a 2017 Women ... CTC’s thirteenth annual Women of Innovation Awards Dinner. , The dinner recognizes women ...
Breaking Biology Technology:
(Date:3/9/2017)... Australia , March 9, 2017 4Dx ... prestigious World Lung Imaging Workshop at the University of ... was invited to deliver the latest data to world ... recognised event brings together leaders at the forefront of ... in lung imaging. "The quality of ...
(Date:3/7/2017)... CITY , March 7, 2017   HireVue ... help top global companies identify the best talent, faster, ... as Chief Sales Officer (CSO) and Diana Kucer ... appointments round out a seasoned executive team poised to drive ... beyond, building on a year of record bookings in ...
(Date:3/2/2017)... Summary This report provides all the information ... partnering interests and activities since 2010. Download the ... Deals and Alliance since 2010 report provides an in-depth ... world,s leading life sciences companies. On demand ... of the most up to date deal and company ...
Breaking Biology News(10 mins):